Schonfeld Strategic Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-546,414
Closed -$6.75M 2591
2024
Q4
$6.75M Buy
546,414
+334,164
+157% +$3.83M 0.04% 411
2024
Q3
$2.42M Sell
212,250
-341,703
-62% -$3.43M 0.02% 808
2024
Q2
$3.96M Buy
553,953
+53,451
+11% +$409K 0.03% 635
2024
Q1
$3.35M Buy
500,502
+476,009
+1,943% +$3.27M 0.02% 791
2023
Q4
$159K Sell
24,493
-27,758
-53% -$179K ﹤0.01% 1568
2023
Q3
$493K Sell
52,251
-13,072
-20% -$157K ﹤0.01% 1213
2023
Q2
$913K Sell
65,323
-257,483
-80% -$4.39M 0.01% 1011
2023
Q1
$6.06M Buy
322,806
+101,606
+46% +$1.67M 0.06% 395
2022
Q4
$3.05M Buy
221,200
+37,939
+21% +$581K 0.03% 661
2022
Q3
$3.5M Buy
183,261
+83,617
+84% +$1.52M 0.03% 657
2022
Q2
$1.52M Buy
99,644
+70,044
+237% +$1.04M 0.01% 835
2022
Q1
$603K Sell
29,600
-23,800
-45% -$485K 0.01% 1252
2021
Q4
$1.56M Sell
53,400
-18,688
-26% -$535K 0.01% 765
2021
Q3
$1.55M Sell
72,088
-21,412
-23% -$517K 0.02% 800
2021
Q2
$2.4M Sell
93,500
-158,000
-63% -$3.37M 0.03% 657
2021
Q1
$4.58M Buy
251,500
+147,800
+143% +$2.46M 0.06% 448
2020
Q4
$1.2M Buy
103,700
+16,200
+19% +$148K 0.02% 750
2020
Q3
$667K Buy
87,500
+48,100
+122% +$364K 0.01% 823
2020
Q2
$259K Buy
+39,400
New +$220K 0.01% 1040
2020
Q1
Sell
-28,600
Closed -$219K 1596
2019
Q4
$219K Sell
28,600
-24,200
-46% -$141K 0.01% 1130
2019
Q3
$280K Buy
+52,800
New +$328K 0.01% 802
2019
Q2
Sell
-442,600
Closed -$1.88M 1299
2019
Q1
$1.88M Sell
442,600
-228,100
-34% -$931K 0.07% 354
2018
Q4
$2.75M Sell
670,700
-21,000
-3% -$110K 0.11% 257
2018
Q3
$4.75M Buy
691,700
+641,700
+1,283% +$3.8M 0.21% 140
2018
Q2
$196K Buy
+50,000
New +$173K 0.01% 705

Other funds holding CDMO

Schonfeld Strategic Advisors's CDMO Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 546,414 shares — an estimated $6.75M sold.

Schonfeld Strategic Advisors first reported a position in CDMO in Q2 2018 and held it in 25 quarters. The position peaked at $6.75M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 546,414 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $6.75M.
  • Schonfeld Strategic Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 25 quarters.
  • Schonfeld Strategic Advisors's Avid Bioservices, Inc. Common Stock position peaked at $6.75M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.